Pharma Strategy and Competitive Intelligence

Today I was at the ophthalmologists office getting my eyes tested for some new glasses. The technician and I were chatting convivially about the pros and cons of Avastin versus Lucentis for wet age-related macular degeneration (AMD). Later, while looking at the National Institutes of Health (NIH) site on the internet, I noticed they have [...]

[Read more →]